The Eagles Autism Foundation is thrilled to announce that West Pharmaceutical Services, a global leader in innovative solutions for injectable drug administration, is generously committing $400,000 in support of the organization's mission to advance autism research and care programs.
The sizeable investment will be split in half as a direct donation to the Eagles Autism Foundation and as a presenting partner of the Eagles Autism Challenge, the team's signature fundraising event. As part of the contribution, West Pharmaceutical Services will serve as the Presenting Sustainability Partner of the Eagles Autism Challenge Finish Line Celebration and also receive naming rights to the event's Sensory Walk (West Sensory Walk).
"We are truly inspired by the generosity of West and would like to thank them for making such a significant contribution to the Eagles Autism Foundation," said Ryan Hammond, Executive Director, Eagles Autism Foundation. "West has given back to our community in so many ways over the years, including their recent partnership supporting our team's Go Green efforts. This is just another example of their incredible leadership and commitment to building better, healthier communities."
Championed by Eagles Chairman and CEO Jeffrey Lurie, the Eagles Autism Challenge presented by Lincoln Financial Group is a one-day bike ride and family-friendly 5K Run/Walk that begins and ends at Lincoln Financial Field. The event features three cycling routes – Wawa Classic 30-Mile Ride, Wawa Shorti 10-Mile Ride, Wawa Junior 10-Mile Youth Ride (13-17 years old) – a 5K Run/Walk and the West Sensory Walk. All five routes end at Lincoln Financial Field with participants crossing the finish line on the field. There is also a virtual participant option for those who want to fundraise but are unable to participate on event day. This event has grown into a global initiative with participants and donors from around the world.
"West is proud to expand our partnership in support of the Eagles Autism Foundation and Eagles Autism Challenge, whose mission is to directly support and advocate for autism research," said Eric M. Green, President, Chief Executive Officer and Chair of the Board of Directors, West. "Giving is a cornerstone of West's culture, and along with our mission, we are connected by a strong responsibility to continue to build a legacy that improves patients' lives through research and building an inclusive community for everyone."
The 7th annual Eagles Autism Challenge will take place on Saturday, May 18, 2024. To register for the event, please visit EaglesAutismChallenge.org. The Eagles Autism Foundation is offering a 50% discount on registration using promo code: Fans24.
Since launching in May 2018, the Eagles Autism Challenge has raised more than $23 million, with one hundred percent of participant-raised funds benefiting institutions conducting innovative autism research and care. Through fundraising efforts, 86 research projects and community grants around the world have been financially supported.
About Eagles Autism Foundation
The Eagles Autism Foundation is dedicated to raising funds for innovative autism research and programs. By providing the necessary resources to doctors and scientists at leading institutions, we will be able to assist those currently affected by autism, as well as future generations. The Foundation aims to inspire and engage the community, so together, we can provide much-needed support to make a lasting impact in the field of autism. Please visit EaglesAutismFoundation.org.
About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 47 billion components and devices each year. In 2023, West commemorated a century of groundbreaking innovation that has shaped the landscape of healthcare and impacted the lives of patients around the world. This milestone served as a testament to West's commitment to revolutionize drug delivery and enhance the overall patient experience. Headquartered in Exton, Pennsylvania, West in its fiscal year 2022 generated $2.89 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit WestPharma.com.
